发明名称 OPHTHALMIC COMPOSITIONS COMPRISING POVIDONE-IODINE
摘要 PROBLEM TO BE SOLVED: To provide ophthalmic compositions suitable for topical application to an eye, effective in the treatment and/or prevention of microbial infection or disorders of at least one tissue of the eye caused by bacteria, mycobacteria, viruses, fungi, or amoebae.SOLUTION: The invention provides an ophthalmic composition containing povidone-iodine in a concentration of 0.01-10%, anti-inflammatory agent such as ketotifen fumarate, diclofenac sodium, flurbiprofen sodium, and ketorolac tromethamine, steroid such as dexamethasone, prednisolone, prednisone, prednisolone acetate, prednisolone sodium phosphate, rimexolone, hydrocortisone, or combinations thereof. Preferably, the ophthalmic composition contains 0.1-2.5% by weight of, particularly preferably 0.5-2% by weight of povidone iodine. The total weight of povidone iodine, antiinflammatory agents, and steroid is 0.1-4.5% in the solution.SELECTED DRAWING: None
申请公布号 JP2016216481(A) 申请公布日期 2016.12.22
申请号 JP20160134980 申请日期 2016.07.07
申请人 CLS PHARMACEUTICALS INC 发明人 SAMSON C MICHAEL;LIANG BO;JOSEPH A CAPRIOTTI
分类号 A61K33/18;A61K9/06;A61K9/08;A61K9/10;A61K9/107;A61K31/167;A61K31/192;A61K31/195;A61K31/245;A61K31/365;A61K31/381;A61K31/407;A61K31/415;A61K31/4535;A61K31/56;A61K31/573;A61K45/00;A61K47/02;A61K47/10;A61K47/12;A61K47/14;A61K47/18;A61K47/20;A61K47/24;A61K47/32;A61K47/34;A61K47/38;A61K47/40;A61P27/02;A61P31/04;A61P31/10;A61P31/12;A61P31/22;A61P33/04;A61P43/00 主分类号 A61K33/18
代理机构 代理人
主权项
地址